Korea to approve AstraZeneca's COVID-19 drug Evusheld this month
Korea to approve AstraZeneca's COVID-19 drug Evusheld this month
Stay updated with breaking news from Astrazeneca Evusheld. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Korea to approve AstraZeneca's COVID-19 drug Evusheld this month
Marion County’s number of newly reported COVID-19 cases increased from the previous reporting period.
Monoclonal antibodies have had their share of ups and downs in the timeline of COVID-19 treatments—but according to ...
Regulators have put different COVID-19 treatments through different degrees of scrutiny, with some relatively safe treatments getting short ...
AstraZeneca’s Evusheld (tixagevimab and cilgavimab, formerly AZD7442) retains neutralisation activity against the emerging Omicron BA.4 and BA.5 (BA.4/5) variants, says preclinical pseudovirus assay data from the University of Oxford.